Compare drug alternatives

Skyrizi® Alternatives

Skyrizi®(Risankizumab-Rzaa)
Taltz®(Ixekizumab)
Prescription Only
Skyrizi, an interleukin inhibitor, is prescribed to alleviate inflammation associated with plaque psoriasis, psoriatic arthritis, or Crohn's disease in adults. The recommended...
Prescription Only
Taltz, a monoclonal antibody, has anti-inflammatory properties and can potentially alleviate symptoms of psoriasis, psoriatic arthritis, or ankylosing spondylitis. Its...
Dosage & AdministrationDosage & Administration comparison data
Administration
Dosing
Latin Shorthand
Financial AssistanceFinancial Assistance comparison data
Out-Of-Pocket Costs With Copay Card
Annual Cap
Assistance Expiration
Generics
No lower-cost generic available
No lower-cost generic available
Physician AdvisoryPhysician Advisory comparison data
Adverse Reactions
Most common adverse reactions are: • Plaque Psoriasis and Psoriatic Arthritis (≥ 1%): upper respiratory infections, headache, fatigue, injection site reactions, and tinea infections. • Crohn’s Disease (>3%): o Induction: upper respiratory infections, headache, and arthralgia. o Maintenance: arthralgia, abdominal pain, injection site reactions, anemia, pyrexia, back pain, arthropathy, and urinary tract infection. . Learn more.
Most common (≥1%) adverse reactions associated with TALTZ treatment are injection site reactions, upper respiratory tract infections, nausea, and tinea infections.. Learn more.
Mechanism of Actions (MoA)
Special Populations
Popular Alternatives
    Relevant Resources
    Skyrizi
    Taltz
    Other indicationsCompare drug alternatives